FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical - pharmaceutical industry, and deals with inhibitor of premature ovulation for application in in vitro fertilisation or in process of transferring embryo, which includes non-peptide compound, which has antagonistic with respect to gonadotropine-releasing hormone activity.
EFFECT: inhibitor of premature ovulation for application in in vitro fertilisation or in process of embryo transfer according to claimed invention is low-toxic, suitable to per oral introduction, and has excellent inhibiting action on premature ovulation in in vitro fertilisation or in process of embryo transfer.
4 cl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
| METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
| NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS | 2019 |
|
RU2768828C1 |
| MECHANOCHEMICAL METHOD FOR THE SYNTHESIS OF COUMARINS | 2022 |
|
RU2799566C1 |
| S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
| SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
| CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
| ANALOGUES OF NONICEPTINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2268883C2 |
| LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
| MODULATORS OF RECEPTOR S1P FOR TREATMENT OF MULTIPLE SCLEROSIS | 2007 |
|
RU2569732C9 |
